Entity
Description
  • Value proposition

    Customized Bioprinting systems and Bioreactors.
    Creating Life Changing Futures.

    REGEMAT3D develops customized Bioprinting Systems and Bioreactors - BMAP. We create Living Tissue Technologies.

    The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration.

    Our mission is to develop innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, to improve people ́s quality of life.

    bioprinting, regenerative medicine, biotechnology, and tissue engineering

Corporate interactions BETA
Corporate TypeTweets Articles
Infineon Technologies
Infineon Technologies
Semiconductors, Semiconductor Manufacturing
Infineon Technologies
Semiconductors, Semiconductor Manufacturing
Other

26 Nov 2024


Eurostat
Eurostat
European Union, Environmental Services
Eurostat
European Union, Environmental Services
Other

26 Nov 2024


Instituto de Biomecánica (IBV) Instituto de Biomecánica (IBV)
Research, footwear
Other

31 Aug 2024


RISE Research Institutes of Sweden
RISE Research Institutes of Sweden
Research, Research Services
RISE Research Institutes of Sweden
Research, Research Services
Other

13 Oct 2023


500 Global
500 Global
Startup accelerator & VC, Venture Capital and Private Equity Principals
500 Global
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

17 Nov 2020


Merck Group
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing
Other

19 Jul 2021


Telefónica
Telefónica
Startup accelerator & VC, Telecommunications
Telefónica
Startup accelerator & VC, Telecommunications
Not capitalistic
Partnership
Not event

24 Mar 2020


Similar entities
Loading...
Loading...
Social network dynamics